Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants priority review to Jazz's pediatric sNDA for Xyrem

June 28, 2018

Vertex patents CFTR modulators

June 28, 2018

Gachon University, Seoul National University identify SIRT1 activators

June 28, 2018

Medivir reports promising topline results from phase IIa extension study of MIV-711

June 28, 2018

Omeros obtains approvals to begin phase I trial with PDE7 inhibitor OMS-527

June 28, 2018

FDA approves Braftovi + Mektovi for unresectable or metastatic melanoma

June 28, 2018

MSDC-5514 - a novel insulin sensitizer to treat diabetes and nonalcoholic steatohepatitis

June 28, 2018

Part A data from phase III HOPE study of voxelotor in sickle cell disease show primary endpoint met

June 28, 2018

Roivant creates new business units and launches Altavant Sciences

June 28, 2018

Aldeyra announces additional clinical programs planned for next year

June 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...